Liquid biopsy is an easy and non-invasive way to detect and treat lung cancer But is it as accurate as traditional biopsies ...

Oxford University researchers have unveiled a new blood test, powered by machine learning, that shows promise in detecting ...

Oxford Cancer Analytics (OXcan) has secured $11m in Series A funding for the development of its liquid biopsy blood tests for ...

Background and objective Gastric cancer (GC) remains a prevalent and preventable disease, yet accurate early diagnostic ...

Oxford University researchers have unveiled a new blood test, powered by machine learning, which shows real promise in ...

Tethis is developing innovative solutions for liquid biopsy, a non-invasive blood test that can detect traces of tumor circulating in the blood. The core of Tethis’ innovation lies in its integrated ...

Breast cancer liquid biopsy industry is projected to witness a CAGR of 22.6% during the period 2024-2032. This growth can be ...

The platform analyses gene expression and cell states specific to individual cells, offering insights for disease diagnosis.

Oxford Cancer Analytics Raises USD$11M in Series A Funding to Transform Early Lung Cancer Detection and Enable Curative ...

In a report released yesterday, Michael Ryskin from Bank of America Securities maintained a Buy rating on Guardant Health (GH – Research ...